Screener
Insulet PODD Accrued Expenses
Accrued Expenses at other companies
Other financials
Where this comes from
Reported directly by Insulet in its filing.
Tagged under the XBRL concept us-gaap:AccruedLiabilitiesCurrent.
The source filing: Insulet’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 4:06 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001145197-26-000169
| (in millions, except share and per share data) | June 30, 2026 | December 31, 2025 |
|---|---|---|
| LIABILITIES AND STOCKHOLDERS’ EQUITY | ||
| Current Liabilities | ||
| Accounts payable | $123.3 | $75.0 |
| Accrued expenses and other current liabilities | 602.0 | 586.7 |
| Current portion of long-term debt | 18.9 | 18.4 |
| Total current liabilities | 744.2 | 680.1 |
| Long-term debt, net | 929.5 | 930.8 |
| Other liabilities | 69.2 | 64.4 |
Item 1. Condensed Consolidated Financial Statements (Unaudited)
FAQ
- What is Insulet's accrued expenses?
- Insulet (PODD) reported accrued expenses of $602M in Q2 2026.
- What is the long-term trend for Insulet's accrued expenses?
- Over 3 years (2020 to 2025), Insulet's accrued expenses has grown at a 62.0% compound annual growth rate (CAGR), from $138.1M to $586.7M.
- What does accrued expenses mean?
- Expenses incurred but not yet paid or invoiced — interest accruals, tax accruals, warranty reserves, and other timing differences.
Ask your AI about Insulet's accrued expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude